title: Is there a clinically relevant interaction between clarithromycin and statins not metabolized by cytochrome P450 3A4?
authors: Metabolism, Interactions and Genomics Group, Wolters Kluwer Health, Hudson, Ohio daniel.streetman@wolterskluwer.com.
authors: Daniel S
authors: DS
authors: Streetman
authors: Metabolism, Interactions and Genomics Group, Wolters Kluwer Health, Hudson, Ohio.
authors: Stephen M
authors: SM
authors: Stout
mesh_terms: D017291:Clarithromycin / Q000009:adverse effects*; D065692:Cytochrome P-450 CYP3A Inhibitors / Q000009:adverse effects*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000378:metabolism* / Q000627:therapeutic use*; D008297:Male
chemical_list: D065692:Cytochrome P-450 CYP3A Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D017291:Clarithromycin
references: NCHS Data Brief. 2014 Dec;(177):1-8
references: 25536410
references: BMJ Open. 2013 Jul 11;3(7):null
references: 23847265
references: CMAJ. 2015 Feb 17;187(3):174-80
references: 25534598
references: Clin Pharmacol Ther. 2014 Oct;96(4):423-8
references: 24918167
references: J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934
references: 24239923
references: N Engl J Med. 2014 Apr 10;370(15):1422-31
references: 24645848
references: Br J Pharmacol. 2009 Oct;158(3):693-705
references: 19785645
references: Clin Pharmacol Ther. 2014 Oct;96(4):470-6
references: 24897241
references: JAMA. 2012 Apr 18;307(15):1580-2
references: 22511681
references: Am J Cardiovasc Drugs. 2015 Feb;15(1):27-34
references: 25348907